Mastering the Valuation of Pharma and Biotech Assets and Businesses Properly valuing drug and biotechnology assets is essential for pharmaceutical enterprises, biotech companies, investors, and other healthcare stakeholders. Valuation provides…
How to Leverage Competitive Intelligence for Smarter In-Licensing Deals for Pharma Business Development and Corporate Development Pharma Business Development and Licensing (BD&L) activities covering pharmaceutical licensing and partnering are integral…
How to Navigate the Discount Rate Conundrum in Biotech and Pharma Valuation In the pharmaceutical and biotechnology industry (referred to collectively as biopharma), almost all valuation and investment decisions decisions…
How to Address Terminal Value Challenges in Pharmaceutical Asset Valuation Several stakeholders who have an interest in pharmaceutical assets employ a multitude of methods to conduct valuations. Among various valuation…